NDC 82922-014 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-014
- Package NDCs from labels
- 82922-014-02
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FOSAPREPITANT DIMEGLUMINE - Truemed Group LLC | Truemed Group LLC | 2022-08-09 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | BluePoint Laboratories | 2d30d839-bb88-46ce-a9ed-66fe32a12a7a | 2026-09-02 | Warnings, Adverse reactions | D35FM8T64X |
| fosaprepitant | FOSAPREPITANT | Mylan Institutional LLC | 9b6d5ea3-2f7a-4501-9a4a-6fa1a7c2d50a | 2026-08-15 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Camber Pharmaceuticals, Inc. | 7dbdf8f5-6936-4143-b52d-96774b799a7d | 2026-08-11 | Warnings, Adverse reactions | D35FM8T64X |
| NAVITRUX | FOSAPREPITANT | AVYXA Pharma, LLC | a41b7c3a-1376-43a7-b5b9-6ba2eba1e169 | 2026-07-29 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT | Northstar Rx LLC | bf207918-100d-4917-88b0-3433c0e72249 | 2026-07-09 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Baxter Healthcare Corporation | 3ed3e0a9-a0a8-4555-9f73-2043e79e3398 | 2026-05-29 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT | Bryant Ranch Prepack | 679c195a-cf59-4ca5-aa05-fa35d08ddb5c | 2026-05-06 | Warnings, Adverse reactions | D35FM8T64X |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Eugia US LLC | 19919480-960b-4741-9611-c133d68512f5 | 2026-04-01 | Warnings, Adverse reactions | D35FM8T64X |
| FOCINVEZ | FOSAPREPITANT DIMEGLUMINE | Steriscience Specialties Private Limited | 18a60093-cec8-1b8c-e063-6394a90a8902 | 2026-03-30 | Warnings, Adverse reactions | D35FM8T64X |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1a7d2f44-b578-4d99-a4ff-f267626064d0 | 2026-03-19 | Warnings, Adverse reactions | D35FM8T64X |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1cc7d482-5d45-4621-9ffc-cd3f7c54614d | 2026-03-19 | Warnings, Adverse reactions | D35FM8T64X |
| EMEND | FOSAPREPITANT DIMEGLUMINE | Merck Sharp & Dohme LLC | 8d66803a-6811-4c29-9c57-e16acfa87f21 | 2026-02-20 | Warnings, Adverse reactions | D35FM8T64X |
| FOSAPREPITANT | FOSAPREPITANT DIMEGLUMINE | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 7375ab3f-a6fc-4601-9415-07b4f681cdef | 2025-12-24 | Warnings, Adverse reactions | D35FM8T64X |
| fosaprepitant | FOSAPREPITANT | BE Pharmaceuticals Inc. | 21b08b87-70e3-4233-9531-dd6d84eab5d0 | 2025-10-09 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT | BluePoint Laboratories | ad89825f-aa31-469f-9685-159a4524dfdc | 2025-10-09 | Warnings, Adverse reactions | D35FM8T64X |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Qilu Pharmaceutical Co., Ltd. | 5bb41bcb-c775-4447-9bd0-d4c55ad110ea | 2025-08-07 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Avenacy, LLC | 3f942e4c-e26a-4155-9e14-344b2970b189 | 2025-07-09 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT | Dr. Reddy's Laboratories Inc., | 557a48d5-0e1f-f3d5-d3bc-db422d19c399 | 2025-05-22 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT | Dr. Reddy's Laboratories Inc., | f34c931c-78b9-90c1-3fa5-bb34a227f2ad | 2024-12-19 | Warnings, Adverse reactions | D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT | Fresenius Kabi USA, LLC | ffee61d1-c1c6-4224-871c-ab7ff6cd01e5 | 2024-06-19 | Warnings, Adverse reactions | D35FM8T64X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.